###begin article-title 0
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
Methylation-dependent silencing at the H19 imprinting control region by MeCP2
###end article-title 0
###begin p 1
To whom correspondence should be addressed at present address: 401 Barker Hall, Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA. Tel: +1 510 642 5007; Fax: +1 510 643 6334; Email: rad1@uclink.berkeley.edu
###end p 1
###begin p 2
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 858 865 858 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 941 944 941 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 949 956 949 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1006 1009 1006 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1212 1215 1212 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1368 1375 1368 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1466 1469 1466 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
Methylation of CpG dinucleotides is correlated with transcriptional repression of genes, including imprinted genes. In the case of the imprinted H19 gene, a 2 kb imprinting control region (ICR) is subject to differential methylation, as it is methylated only on the silenced paternal allele. This region has previously been shown to act as a silencer element at the endogenous locus. The proteins that bind at the H19 differentially methylated domain (DMD) and mediate transcriptional silencing have yet to be identified, although a family of proteins containing a methyl-CpG-binding domain (MBD), of which MeCP2 is the best characterised, are obvious candidates. MeCP2 can bind to a single methylated CpG dinucleotide through its MBD and also contains a transcriptional repression domain (TRD). The TRD interacts with Sin3a and histone deacetylases (HDACs) in vivo, forming a repressive complex. Here we show that MeCP2 is recruited to the H19 DMD in vivo and can silence a reporter gene regulated by the H19 DMD in a methylation-dependent manner. This repression can be alleviated by deletion of the TRD from MeCP2 or by inhibition of HDAC activity. These data indicate that transcriptional silencing from the H19 ICR involves recruitment of MeCP2 and presumably an associated protein complex with deacetylase activity. This complex may also be recruited to the ICR in vivo, resulting in a compact, repressive chromatin structure capable of silencing the paternal H19 allele.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c1">1</xref>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c2">2</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c5">5</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c6">6</xref>
###xml 515 518 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 640 643 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 796 797 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c7">7</xref>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c8">8</xref>
###xml 832 835 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 980 981 980 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c9">9</xref>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c10">10</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c11">11</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c12">12</xref>
Genomic imprinting is responsible for the parental allele-specific expression of a subset of genes in the mammalian genome. Silencing of one of the parental alleles requires DNA methylation (1) and chromatin structural modifications (2-5). A strong correlation exists between CpG methylation and transcriptional repression at a number of genes (6). However, the precise mechanisms by which these epigenetic modifications induce transcriptional repression at imprinted loci are poorly understood. In the case of the H19 gene the paternally inherited allele is silenced. A 2 kb CpG-rich differentially methylated domain (DMD) upstream of the H19 gene is essential for repression and a 1.2 kb region within the DMD functions specifically as a silencer element on the methylated paternal chromosome (7,8). The proteins that bind at the H19 DMD and mediate this silencing have yet to be identified, although a family of proteins containing a conserved methyl-CpG-binding domain (MBD) (9,10), of which MeCP2 (11,12) is the best characterised, are obvious candidates.
###end p 4
###begin p 5
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c13">13</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c14">14</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c15">15</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c16">16</xref>
MeCP2 can bind to a single methylated CpG dinucleotide through its MBD and interacts with Sin3a and histone deacetylases (HDACs) through a transcriptional repression domain (TRD) in vivo, forming a repressive complex (13,14). The TRD is also capable of interacting with TFIIB, a component of the basal transcription machinery (15,16), suggesting that it may also be capable of causing repression independently of HDAC activity.
###end p 5
###begin p 6
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c17">17</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c6">6</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c18">18</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c21">21</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c22">22</xref>
###xml 455 462 455 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c23">23</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c24">24</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c25">25</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c26">26</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c27">27</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 140 146 <span type="species:ncbi:9606">humans</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
In mice, MeCP2 is particularly abundant in the brain (17) and mutations in MeCP2 have recently been shown to contribute to Rett syndrome in humans (6,18-21), an X-linked neurodevelopmental disorder that is one of the most common causes of mental retardation in females (22). These mutations affect the ability of the protein to repress transcription either by impairing selectivity for methylated DNA binding or by decreasing the stability of the protein in vivo (23,24). MeCP2 is required for normal post-natal neurological development in mice (25,26). However, its role in regulating gene expression earlier in development is unknown and this role may be difficult to establish accurately because of possible functional redundancy amongst the MBD family members (27).
###end p 6
###begin p 7
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 276 279 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vivo</italic>
###xml 610 617 610 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 644 647 644 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
In this study we have investigated whether MeCP2 mediates transcriptional repression from the H19 DMD. Using chromatin immunoprecipitation (ChIP) with an anti-MeCP2 antibody, coupled with PCR amplification of the immunoprecipitated DNA, we show that MeCP2 is recruited to the H19 DMD in vivo. Using a HeLa cell transfection assay we also demonstrate that transcriptional repression from the DMD is mediated by MeCP2 in a methylation-dependent manner and requires the TRD of the protein. Transcriptional repression can be almost completely alleviated by inhibition of HDAC activity. These data demonstrate that in vivo silencing of the paternal H19 allele from the DMD involves DNA methylation and the possible recruitment, through MeCP2 and Sin3a, of a HDAC, which presumably acts to ensure an inactive repressed chromatin state.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
HeLa cell transfection reporter assay
###end title 9
###begin p 10
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlu</italic>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 137 141 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Regions from the mouse H19 DMD were amplified by PCR and cloned into the MluI site in the pGL3-Promoter vector (Promega), upstream of an SV40 promoter driving a firefly luciferase reporter gene, and sequenced to confirm integrity and orientation. The following PCR primers were used: full-length DMD, 4S (5'-TGCCTACAGTTCCCGAATCACC-3') and 2AS (5'-CGGCATCGTCTGTCCATTTAGC-3'); 5'-DMD, 4S and 2.8AS (5'-GCTTTTCTGCTTTCTGGCATCG-3'); 3'-DMD, 2.8S (5'-AGCCGTTGTGAGTGGAAAGACC-3') and 2AS; mid DMD, 3.1S (5'-AACCGCCAACAAGAAAGTCTGG-3') and 2.6AS (5'-GCTTCGGACATTGCTGTGGG-3'); down DMD, 2.6S (5'-AAGCCGCTATGCCTCAGTGG-3') and 2AS.
###end p 10
###begin p 11
###xml 247 254 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 621 624 613 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sss</italic>
###xml 672 673 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 755 756 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
An aliquot of 2 microg of these DNA constructs was transfected into HeLa cells which were cultured for 20 h. The cells were lysed and luciferase levels were measured. The firefly luciferase values were normalised against 0.2 microg co-transfected Renilla luciferase reporter gene driven by a thymidine kinase (TK-Renilla) promoter, as described in the Dual-Luciferase Reporter Assay System protocol (Promega). Each construct was tested in triplicate in each experiment, and the experiments were repeated a minimum of three times. The constructs were either unmethylated or fully methylated at all CpGs by incubation with SssI methylase (NEB) in the presence of 160 microM S-adenosylmethionine in NEB buffer 2 (50 mM NaCl, 10 mM Tris-HCl pH 7.9, 10 mM MgCl2, 1 mM DTT) at 37degreesC for 16 h. Cells transfected with TK-Renilla alone demonstrated no firefly luciferase activity.
###end p 11
###begin p 12
###xml 192 195 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 201 204 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 588 591 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 634 638 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To test the effect of MeCP2 expression, constructs were generated containing full-length human MeCP2 or MeCP2 lacking the TRD (residues 207-310), designated MeCP2 DeltaTRD, cloned between the KpnI and XhoI sites of the mammalian expression vector pcDNAI (Invitrogen). The inserts were generated by PCR from the plasmid Actin5C.MeCP2 (a gift of S. Kudo). The Rett mutation, R306C, was introduced into the MeCP2 construct using the QuikChange mutagenesis kit (Stratagene). All constructs were checked by automated DNA sequencing. The Ezh1 expression construct (pKW2T/Ezh1#10) consists of a CMV promoter, the Ezh1 open reading frame and SV40 poly(A) tail and was a gift from T. Jenuwein.
###end p 12
###begin title 13
Anti-MeCP2 antibody
###end title 13
###begin p 14
###xml 136 152 136 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 328 329 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 400 401 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 401 402 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 531 532 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 532 533 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 570 571 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 571 572 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 27 34 <span type="species:ncbi:9986">rabbits</span>
###xml 95 98 <span type="species:ncbi:10116">rat</span>
###xml 136 152 <span type="species:ncbi:562">Escherichia coli</span>
###xml 227 230 <span type="species:ncbi:10116">rat</span>
###xml 406 409 <span type="species:ncbi:10116">rat</span>
An antiserum was raised in rabbits against the His-tagged recombinant methyl-binding domain of rat MeCP2 (residues 78-164) expressed in Escherichia coli from plasmid pET6HMBD, which was a gift from A. Bird. In western blots of rat liver and brain nuclei, used at 1 in 1000 dilution, it recognised a single band with an apparent Mr of approximately68 000 in an SDS-12% polyacrylamide gel. (The actual Mr of rat MeCP2 is 53 014, but it migrates anomalously; authentic recombinant MeCP2 with a 20 residue N-terminal tag, whose actual Mr is 55 022 migrates with an apparent Mr of approximately70 000.)
###end p 14
###begin title 15
Chromatin immunoprecipitation assay
###end title 15
###begin p 16
###xml 0 49 0 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crosslinking, sonication and immunoprecipitation.</italic>
###xml 66 69 66 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">260</sub>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c28">28</xref>
###xml 188 189 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 994 995 976 977 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
Crosslinking, sonication and immunoprecipitation. Samples of 400 A260 units of nuclei (28) isolated from adult or neonate mouse liver were resuspended in 5 ml of 0.32 mM sucrose, 1 mM MgCl2, 1 mM phenylmethylsulphonyl chloride. The nuclei were crosslinked with 1% formaldehyde (added from a 38% stock; Sigma) at room temperature with gentle shaking for 15 min and the reaction was then quenched with 125 mM glycine (added from a 2.5 M stock). After 5 min further incubation at room temperature the nuclei were collected by centrifugation (5000 r.p.m. for 5 min at 4degreesC in a Sorvall SS34 rotor), washed twice in ice-cold buffer (2 mM potassium phosphate, pH 7.4, 0.15 M NaCl) and resuspended in 0.25 ml lysis buffer (50 mM HEPES, pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% v/v Triton X-100, 0.1% w/v sodium deoxycholate) supplemented with protease inhibitors (0.24 mg/ml aminoethylbenzenesulphonyl fluoride, 1 microg/ml leupeptin, 1 microg/ml aproteinin, 1.56 mg/ml benzamidine, 20 microg/ml tosyl-l-chloroketone; all from Sigma). The nuclei were sonicated in an ice-water bath to shear the chromatin with three 8 s pulses of 2.5 kV with a rest interval of 20 s; the resulting average DNA size was approximately0.6 kb (range approximately0.25-2.0 kb). The lysate was cleared by centrifugation (twice for 5 min at 13 000 r.p.m. at 4degreesC in a microfuge).
###end p 16
###begin p 17
###xml 900 901 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
An aliquot of 1.25 microl of anti-MeCP2 antiserum (or 1.25 microl of preimmune serum) was added to 100 microl of the formaldehyde-crosslinked chromatin and the samples (and crosslinked chromatin alone) were mixed on a rotator for 2 h at 4degreesC. Sepharose-protein A beads (15 microl) (Pharmacia) were added and the samples mixed for a further 2 h at 4degreesC. The beads, with bound chromatin fragments, were collected by centrifugation (1 min at 13 000 r.p.m. in a microfuge at 4degreesC); the unbound fraction was retained for analysis by western blotting (see below). The beads were washed successively, each for 5 min on a rotator, with 1 ml lysis buffer (see above), 1 ml wash buffer 1 (50 mM HEPES pH 7.5, 500 mM NaCl, 1 mM EDTA, 1% v/v Triton X-100, 0.1% w/v sodium deoxycholate), 1 ml wash buffer 2 (10 mM Tris-HCl pH 8.0, 0.5% v/v NP40, 0.5% w/v sodium deoxycholate, 1 mM EDTA, 0.14 M LiCl2) and finally 1 ml TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA). The final wash was retained for western analysis. The washed beads were resuspended in 60 microl elution buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% w/v SDS) and incubated at 65degreesC for 10 min to release bound (immunoprecipitated) chromatin fragments. The beads were then removed by centrifugation (10 min at 13 000 r.p.m. in a microfuge). An aliquot of 20 microl of the supernatant was retained for DNA extraction.
###end p 17
###begin p 18
###xml 421 422 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
To 20 microl of eluted crosslinked chromatin (or input sonicated chromatin) was added 110 microl TE containing 1% SDS and the samples were incubated at 65degreesC for 12 h to reverse the protein-DNA crosslinks. They were then allowed to cool to room temperature and deproteinised by digestion with 100 microg proteinase K in the presence of 2 microg glycogen at 37degreesC for 1 h. To this was added 25 microl of 5 M LiCl2 and the DNA was extracted with phenol:chloroform:isoamyl alcohol (25:24:1 v/v) and ethanol precipitated. 'Input' DNA samples were resuspended in 50 microl TE and 'immunoprecipitated' DNA samples were resuspended in 250 microl TE for the PCR (see below).
###end p 18
###begin p 19
###xml 561 572 <span type="species:ncbi:3704">horseradish</span>
###xml 611 617 <span type="species:ncbi:9793">donkey</span>
###xml 623 629 <span type="species:ncbi:9986">rabbit</span>
Crosslinked proteins present in 1/25th of the input chromatin, the fraction not bound to beads, the final TE wash from beads and the fraction bound by beads were released from DNA by heating at 90degreesC for 10 min in elution buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% w/v SDS), collected by precipitation with 25% (final) trichloroacetic acid, washed with acetone/10 mM HCl followed by acetone and then analysed by western blotting (using anti-MeCP2 and preimmune serum) after electrophoresis in an SDS-12% polyacrylamide gel. Bound MeCP2 was detected with horseradish peroxidase-linked secondary antibody (donkey anti-rabbit; Amersham Pharmacia) coupled to the enhanced chemiluminescence detection system (Amersham Pharmacia).
###end p 19
###begin p 20
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Polymerase chain reaction.</italic>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 179 182 179 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 219 222 <span type="species:ncbi:10116">rat</span>
###xml 263 266 <span type="species:ncbi:10116">rat</span>
Polymerase chain reaction. The sequences of the PCR primers used to amplify selected genes in the ChIP assay were as follows: mouse H19 3.1S (5'-AACCGCCAACAAGAAAGTCTGG-3'); mouse H19 2.6AS (5'-GCTTCGGACATTGCTGTGGG-3'); rat H19 forward (5'-CCCGGTATTGGAATCCAC-3'); rat H19 reverse (5'-GAAATGCATGTGTCCTGCCCTCC-3'); GAPDH forward (5'-CATTAACGTCAACTACATGG-3'); GAPDH reverse (5'-TGATGACCAGCTTCCCATTCTCAGC-3').
###end p 20
###begin p 21
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 500 503 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 125 128 <span type="species:ncbi:10116">rat</span>
###xml 214 217 <span type="species:ncbi:10116">rat</span>
The primers for the mouse H19 DMD amplify a region -2.6 to -3.1 kb upstream of the transcription start site. The primers for rat GAPDH amplify a 100 bp region at the start of the coding region of this gene and the rat H19 primers a 100 bp region -2 to -2.1 kb upstream of the transcription start site. The number of cycles of PCR required to give a linear response was determined for each primer set and these conditions were used to amplify the DNA immunoprecipitated in the ChIP assay, using 2.5 U Taq polymerase (Promega). The programme consisted of a hot start of 95degreesC for 5 min followed by 24-28 cycles of a denaturing step (95degreesC for 30 s), an annealing step (50degreesC for 30 s) and an elongation step (72degreesC for 30 s), followed by a final elongation step of 72degreesC for 10 min. Controls with no DNA or genomic DNA were included. The PCR products were analysed in an 8% polyacrylamide-Tris acetate/EDTA gel which was stained with 0.5 microg/ml ethidium bromide and viewed on a UV transilluminator.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
MeCP2-mediated silencing from methylated H19 DMD
###end title 23
###begin p 24
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c27">27</xref>
In order to test whether MeCP2 mediates transcriptional repression from the H19 DMD we used a HeLa cell transfection assay. The aim of this in vitro study was to analyse the direct effect of MeCP2 on transcriptional regulation from the H19 DMD, which may not be possible with targeted mutations in vivo due to functional redundancy amongst the MBD-containing proteins (27).
###end p 24
###begin p 25
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c29">29</xref>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 347 348 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 371 374 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 380 383 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 387 388 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 542 543 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 694 695 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 711 712 699 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 829 832 817 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 868 870 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c26">26</xref>
###xml 1040 1043 1028 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1149 1150 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 1322 1325 1286 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1516 1521 1480 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MeCP2</italic>
###xml 1570 1571 1534 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 56 60 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 522 526 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 568 573 <span type="species:ncbi:9606">human</span>
###xml 698 702 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 807 811 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1226 1230 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The full-length mouse H19 DMD was cloned upstream of an SV40 promoter-driven firefly luciferase reporter gene (Fig. 1A) and transfected into HeLa cells, which lack endogenous MeCP2 (29). When unmethylated this construct (designated H19 DMD) gives approximately2-fold repression over the corresponding construct containing the promoter alone (Fig. 1B). Methylation of the H19 DMD (H19 DMDm) caused a significant increase in repression, which can only be partially attributed to direct methylation-mediated silencing of the SV40 promoter (Fig. 1B). Co-transfection of a human MeCP2-expressing vector with the methylated promoter sequence alone did not mediate further significant silencing (Fig. 1B, SV40 promoterm + MeCP2). This observation is consistent with the continued repression seen from a methylated SV40 promoter in MeCP2-/- cells, just as in wild-type cells (26), and suggests that MeCP2 does not mediate significant repression on the promoter alone. In contrast, co-transfection of the MeCP2-expressing vector with the methylated H19 DMD reporter construct caused an approximately5.5-fold increase in repression of the reporter gene (Fig. 1B), corresponding to approximately200-fold repression over the unmethylated SV40 promoter alone. Significantly, MeCP2-mediated silencing is dependent on methylation of the H19 DMD, since no repression occurred in the absence of DNA methylation. The repression is also dose dependent, as shown by proportionate reductions in repression when 200, 100 and 50 ng of the MeCP2 vector, respectively, were co-transfected (Fig. 1B).
###end p 25
###begin p 26
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ezh1</italic>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c30">30</xref>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ezh1</italic>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 762 763 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 818 825 818 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 944 947 944 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 965 966 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c7">7</xref>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
###xml 1132 1136 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To examine the specificity of the MeCP2-mediated silencing we also tested the effect of Ezh1, a member of the Polycomb group of heterochromatin proteins, which has a role in gene silencing (30). Co-transfection of a mouse Ezh1 expression construct with either the unmethylated or methylated H19 DMD construct caused no additional repression (data not shown). We also examined MeCP2-mediated repression from four sub-regions of the H19 DMD (Fig. 1A). In contrast to the full-length DMD, none of the methylated sub-regions exhibited significant repression when MeCP2 was co-transfected in this assay (data not shown), despite the approximately equivalent density of CpGs between all the sub-regions and full-length DMD (1 CpG dinucleotide every 30-41 nt; see Fig. 1A). This observation is in agreement with our previous in vivo studies, where methylation of a 1.1 kb segment from the 5'-region of the DMD alone is not sufficient for silencing of H19 in many tissues (7), suggesting that the total number of CpGs is important for repression. It is also possible that the size of the region from the DMD, or its spacing relative to the SV40 promoter, are important for repression, as the sub-regions are all smaller than the full-length DMD.
###end p 26
###begin title 27
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
Inhibition of HDAC activity relieves H19 DMD-mediated repression
###end title 27
###begin p 28
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 236 237 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f2">2</xref>
###xml 339 341 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c20">20</xref>
###xml 379 382 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 393 394 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f3">3</xref>
###xml 494 501 486 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 511 513 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c24">24</xref>
###xml 608 610 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c13">13</xref>
###xml 611 613 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c14">14</xref>
###xml 664 667 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 922 924 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c31">31</xref>
###xml 979 982 971 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 992 995 984 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1021 1022 1013 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f2">2</xref>
###xml 1144 1145 1136 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f2">2</xref>
###xml 1238 1241 1230 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
###xml 494 501 <span type="species:ncbi:8355">Xenopus</span>
###xml 987 991 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To determine whether MeCP2-mediated repression at the H19 DMD requires the TRD of MeCP2, a deletion mutant of MeCP2 (DeltaTRD), lacking the TRD, was tested in the transfection assay. The DeltaTRD mutant had no repressive activity (Fig. 2A). A mutation (R306C, very near the C-terminal end of the TRD) found in some Rett syndrome patients (20) did not disrupt repression from the H19 DMD (Fig. 3A), in agreement with another study in which effects on transcription were tested by injection into Xenopus oocytes (24). The TRD of MeCP2 has been shown to interact with the co-repressor molecule Sin3a and HDACs (13,14). To test whether the recruitment of HDACs to the H19 DMD is responsible for repression from this control region in this assay we analysed expression of the transfected reporter construct in the presence of co-transfected MeCP2-expressing vector and trichostatin A (TSA), a known inhibitor of HDAC activity (31). TSA had no effect on expression of the unmethylated H19 DMD-SV40-luc reporter construct (Fig. 2B). However, repression of the methylated reporter construct in the presence of MeCP2 was alleviated by >95% by TSA (Fig. 2B), suggesting that histone deactylation is the predominant mechanism of repression from the H19 DMD.
###end p 28
###begin title 29
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
MeCP2 is associated with the H19 differentially methylated domain in vivo
###end title 29
###begin p 30
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c32">32</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c33">33</xref>
###xml 320 321 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 321 322 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 577 580 553 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 591 592 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f3">3</xref>
###xml 752 753 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f3">3</xref>
###xml 776 779 752 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 874 875 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c7">7</xref>
###xml 1010 1013 986 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1093 1096 1069 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1164 1169 1140 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 187 190 <span type="species:ncbi:10116">rat</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
###xml 1105 1108 <span type="species:ncbi:10116">rat</span>
To investigate whether endogenous MeCP2 was recruited to the H19 DMD in vivo, we used ChIP (32,33) with an anti-MeCP2 antibody. The antibody we raised specifically detects MeCP2 in adult rat liver nuclei, where a single band is observed at approximately68 kDa, corresponding to MeCP2 (which migrates anomalously slowly, Mr approximately53 kDa), and in formaldehyde-crosslinked and sonicated chromatin (data not shown). MeCP2 is immunoprecipitated by the antiserum, but not by the preimmune serum. In experiments on both adult and neonatal mouse liver, a 0.5 kb region from the H19 DMD (Fig. 3A) could be amplified from the immunoprecipitated DNA (after reversal of the crosslinks), showing that MeCP2 was recruited to this region in both tissues (Fig. 3B). In neonatal liver, H19 is predominantly expressed only from the maternal allele and silenced on the paternal allele (7). The association of MeCP2 therefore correlates both with general repression in adult tissue and with repression in a tissue in which H19 is imprinted. MeCP2 can also be detected by ChIP at the region upstream of the H19 gene in rat liver and brain, but not at the ubiquitously expressed GAPDH gene in these tissues (data not shown).
###end p 30
###begin title 31
DISCUSSION
###end title 31
###begin p 32
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c34">34</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c37">37</xref>
###xml 487 490 487 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c7">7</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c37">37</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
At the mouse H19/Igf2 genomic locus the DMD upstream of H19 acts as a cis-regulatory imprinting control region (ICR). The activity of the DMD is modified depending on its methylation status. On the maternal chromosome it is unmethylated and is proposed to act as an insulator, capable of disrupting the interaction of downstream enhancers with the Igf2 promoter (34-37). Conversely, on the paternal chromosome the methylated DMD contains a silencer element responsible for repression of H19 (7,37). Here we show that repression from this silencer element is mediated by recruitment of MeCP2 and possibly an associated protein complex containing HDACs, capable of modifying chromatin structure.
###end p 32
###begin p 33
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c3">3</xref>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 297 304 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vivo</italic>
###xml 372 375 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 411 419 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 528 535 528 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 568 571 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f3">3</xref>
###xml 806 813 806 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f1">1</xref>
###xml 893 896 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 928 933 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1174 1181 1174 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c27">27</xref>
###xml 1268 1271 1268 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1303 1306 1303 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1395 1402 1395 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1457 1458 1457 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c7">7</xref>
###xml 1602 1605 1602 1605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1616 1617 1616 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c8">8</xref>
###xml 1647 1649 1647 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c38">38</xref>
###xml 1762 1765 1762 1765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
Recent studies have revealed that in the H19/Igf2 imprinted domain it is only in the DMD/promoter region of the H19 gene that there is a correlation between DNA methylation, histone H4 hypoacetylation and transcriptional repression (3). Our data demonstrate that MeCP2 is recruited to the H19 DMD in vivo. This factor can facilitate silencing of a reporter gene from this cis-acting ICR in a transfection assay in vitro. DNA methylation is required for MeCP2-mediated repression and this repression is therefore likely to occur in vivo only on the methylated paternal H19 allele (Fig. 3C). Sub-regions of the methylated DMD are not sufficient to mediate additional repression when MeCP2 is co-expressed. As the 3'-DMD fragment we tested overlaps extensively with the silencer region identified by deletion in vivo (see Fig. 1A), this suggests that transcriptional repression at the endogenous H19 locus may be mediated by other trans-acting factors in addition to MeCP2. Different members of the MBD-containing family of proteins are obvious candidates for this role. Indeed, the existing genetic evidence points to some level of functional redundancy amongst these factors in vivo (27). While our study does not address the role of MeCP2-mediated repression from the H19 ICR directly on the endogenous H19 promoter, we have previously shown that deletion of the MeCP2-binding region at the DMD in vivo results in reactivation of endogenous H19 expression (7). In addition, transgenic studies have demonstrated that the silencer region from the DMD is capable of repressing transcription both from the H19 promoter (8) and heterologous promoters (38), indicating that the repression is not promoter specific but may be a consequence of promoter proximity to the H19 ICR silencer.
###end p 33
###begin p 34
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c3">3</xref>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c5">5</xref>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f3">3</xref>
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf210c5">5</xref>
###xml 724 727 724 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 932 933 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf210f3">3</xref>
The silencing mediated by MeCP2 via the full-length H19 DMD in the transfection assay can be almost completely alleviated by inhibition of HDAC activity, suggesting that deacetylases play a major role in facilitating repression. The targets of this repressive deacetylation activity at the endogenous locus are likely to include the tails of histones located within or close to the H19 ICR on the paternal allele (3,5; Fig. 3C). It is known that at the endogenous H19 locus the level of acetylation on histones H3 and H4 is important for gene regulation, as the silenced paternal allele is hypoacetylated and the expressed maternal allele is hyperacetylated (5). In our model, the absence of DNA methylation on the maternal H19 allele would prevent binding of the repressive complex, facilitating acetylation of histones and potentially allowing the recruitment of factors necessary for transcriptional activation of the gene (Fig. 3D). The existence of differentially methylated genomic regions at a number of genes exhibiting allele-specific expression will make it of interest to examine whether similar mechanisms of transcriptional regulation are employed at other imprinted loci.
###end p 34
###begin title 35
Figures and Tables
###end title 35
###begin p 36
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 95 96 95 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cfo</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 846 849 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 857 860 857 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsp</italic>
###xml 867 870 867 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 879 882 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 887 888 887 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 993 996 993 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1041 1044 1041 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlu</italic>
###xml 1247 1250 1247 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1362 1363 1362 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 987 992 <span type="species:ncbi:10090">mouse</span>
###xml 1105 1109 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1219 1223 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1286 1290 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1527 1531 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 MeCP2 represses transcription from the methylated H19 DMD in a HeLa cell transfection assay. (A) Schematic representation of the H19 gene and 4 kb upstream sequence. Individual methylation-sensitive CfoI restriction enzyme sites in the H19 promoter and upstream region are shown as unmethylated on the maternal chromosome (open circles, above line) or methylated on the paternal chromosome (filled circles, below line). Vertical arrows indicate DNase I hypersensitive sites, which are clustered on the maternal chromosome. The lower part of the figure shows the 1.2 kb silencer element (white box), 2 kb differentially methylated domain (grey box) and the sub-regions tested in the cell transfection assay (see text). The number of CpG dinucleotides and the mean separation (in bp) of CpGs in the regions tested are indicated in parentheses. B, BamHI; Bs, BspEI; H, HindIII; R, EcoRI. (B) Repression of transfected firefly luciferase reporter constructs in HeLa cells. Regions from the mouse H19 DMD, amplified by PCR, were cloned into the MluI site in the pGL3-Promoter vector (Promega), upstream of an SV40 promoter driving a firefly luciferase reporter gene, and sequenced to confirm integrity and orientation. The SV40 promoter alone and the H19 differentially methylated domain + SV40 promoter (H19 DMD) constructs were tested unmethylated and methylated (m). A MeCP2-expressing vector (200, 100 or 50 ng) was transfected as indicated. Light emission values were normalised with respect to the value for the unmethylated SV40 promoter alone, taken as 1. Error bars show calculated SEM values.
###end p 36
###begin p 37
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 461 464 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 553 554 545 546 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 703 706 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 230 235 <span type="species:ncbi:9606">human</span>
###xml 469 473 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 707 711 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 MeCP2-mediated repression is linked to HDAC recruitment. (A) Comparison of repression mediated by wild-type (WT), TRD-deleted (DeltaTRD) and R306C mutant MeCP2 expression vectors. Constructs were generated containing full-length human MeCP2, MeCP2 lacking the transcriptional repression domain (residues 207-310), designated MeCP2 DeltaTRD, or the Rett mutation MeCP2 (R306C). Light emission values were normalised with respect to the value for the methylated H19 DMD-SV40 promoter-firefly luciferase construct. Error bars show calculated SEM values. (B) The effect of TSA on repression of transfected constructs. Repression, on addition of an MeCP2-expressing vector, of an unmethylated or methylated H19-SV40 promoter-firefly luciferase reporter construct in the absence (-TSA) or presence (+TSA) of 100 mM TSA is shown. TSA alleviates >95% of the repression observed for the methylated construct in the absence of TSA.
###end p 37
###begin p 38
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 48 49 48 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 179 180 179 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 979 982 979 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msp</italic>
###xml 987 988 987 988 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 993 994 993 994 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1047 1050 1047 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1076 1079 1076 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1303 1306 1303 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1363 1366 1363 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1393 1396 1393 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 1648 1651 1648 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H19</italic>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 1226 1233 <span type="species:ncbi:301928">ellipse</span>
 MeCP2 is associated with the H19 ICR in vivo. (A) The primers for mouse H19 DMD amplify a region -3.1 to -2.6 kb upstream of the transcription start site (mid DMD PCR primers). (B) PCR amplification of DNA co-immunoprecipitated with the MeCP2 antibody from mouse adult and neonatal liver chromatin. Formaldehyde-crosslinked, sonicated chromatin fragments were immunoprecipitated with anti-MeCP2 antiserum and Sepharose-protein A beads or with preimmune serum. Protein-DNA crosslinks in the chromatin immunoprecipitated with both preimmune (as a control) and MeCP2 antisera were reversed and the 527 bp region from the H19 DMD was amplified by PCR and in parallel amplified from input DNA (not immunoprecipitated). MeCP2 was detected in the bound fraction in both adult and neonatal liver chromatin. The number of cycles of PCR required to give a linear response was determined. N, no DNA; I, input; P, preimmune; B, bound (MeCP2 serum-precipitated DNA); M, size markers (pBR322/MspI). (C and D) Model of methylation-dependent repression from the H19 ICR. (C) At the paternal H19 allele, DNA methylation (filled circles) at the DMD is recognised by MeCP2. MeCP2 is capable of recruiting Sin3a and HDACs via its TRD (dark grey ellipse). HDACs act locally to deacetylate the tails of histones proximal to H19, resulting in chromatin compaction and silencing of the H19 gene. (D) At the maternal H19 allele the absence of DNA methylation (open circles) at the DMD prevents recruitment of the MeCP2/Sin3a/HDAC complex. The histones in the region therefore remain acetylated and the chromatin is accessible to factors necessary for transcription of the H19 gene.
###end p 38
###begin title 39
ACKNOWLEDGEMENTS
###end title 39
###begin p 40
###xml 114 119 <span type="species:ncbi:9606">human</span>
We thank Teca Galvao for providing the recombinant MBD of MeCP2 used to raise an antiserum, Prof. S. Kudo for the human MeCP2 clone and Esther Bae, Katharine Arney and Michael Levine for helpful comments on the manuscript. R.A.D. acknowledges receipt of a Wellcome Trust Prize Studentship and Fellowship and C.J.G of a Medical Research Council Studentship. This work was supported by grants from the Wellcome Trust to M.A.S. and J.O.T.
###end p 40
###begin title 41
REFERENCES
###end title 41

